Traws Pharma, Inc.
A clinical-stage biopharmaceutical company focused on discovering and developing novel medicines for infectious diseases and oncology. The company is currently developing and clinically testing narazaciclib for influenza, COVID-19 and other respiratory viral infections, as well as low-grade endometrial stromal sarcoma. The company is based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Pennsylvania |
Employees | 17 |
Founded | 1998 |
Financials | |
|---|---|
Market Capitalization | 10.07M |
Revenue | 0.23M |
Operating Income | -19.37M |
Operating Margin | -8572.12% |
Net Income | -18.16M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3936 / 5373 |
Sector : Healthcare | 486 / 1144 |
Industry : Biotechnology | 176 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 5194 / 5565 |
Sector : Healthcare | 1026 / 1182 |
Industry : Biotechnology | 577 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3754 / 5436 |
Sector : Healthcare | 460 / 1164 |
Industry : Biotechnology | 177 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4850 / 5330 |
Sector : Healthcare | 978 / 1174 |
Industry : Biotechnology | 508 / 667 |